Papillary Renal Cell Carcinoma Completed Phase 2 Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0030667 (Papillary Renal Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00335556Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsTreatment